These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 2205987)

  • 21. [The effect of immunoscintigraphy with monoclonal antibodies on assays of hormones and tumor markers. This is not the end of the matter!].
    Janssen JA; Blankestijn PJ; Docter R; Blijenberg BG; Lamberts SW; Krenning EP
    Ned Tijdschr Geneeskd; 1989 Jul; 133(29):1455-8. PubMed ID: 2571949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Lymphocyte hybridization and cancerology: diagnostic and therapeutic applications. Example of tumor markers].
    Cazin JL; Gosselin P; Demaille A
    Pathol Biol (Paris); 1993 Nov; 41(9):881-6. PubMed ID: 8121720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The importance of monitoring colorectal adenomas by tumor markers (ROC analysis).
    Stajic S; Novaković R; Kostić N; Josifovski J; Simić P; Katić V; Kovijanić M
    Med Pregl; 1993; 46 Suppl 1():69-71. PubMed ID: 8569613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential clinical utility of monoclonal antibodies in the management of human carcinomas.
    Schlom J; Weeks MO
    Important Adv Oncol; 1985; ():170-92. PubMed ID: 3916739
    [No Abstract]   [Full Text] [Related]  

  • 25. Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker.
    Hylton N
    J Clin Oncol; 2006 Jul; 24(20):3293-8. PubMed ID: 16829653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What's new in cancer monitoring?
    Matzku S
    Pathol Res Pract; 1987 Oct; 182(5):699-703. PubMed ID: 3317325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunohistochemistry in malignant mesothelioma].
    Mezger J
    Pathologe; 1989 May; 10(3):197. PubMed ID: 2740287
    [No Abstract]   [Full Text] [Related]  

  • 28. [Future prospects for the use of tumor markers].
    Grunicke H
    Wien Klin Wochenschr; 1989 Jul; 101(14):472-5. PubMed ID: 2672607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoclonal antibodies to detect markers specific for tumors.
    Klavins JV
    Ann Clin Lab Sci; 1987; 17(4):221-5. PubMed ID: 3619397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Serum diagnosis of cancer with monoclonal antibodies].
    Kannagi R
    Rinsho Byori; 1989 Jul; (Spec No 82):52-86. PubMed ID: 2575677
    [No Abstract]   [Full Text] [Related]  

  • 31. [Tumor markers].
    Hattori N
    Gan No Rinsho; 1986 Aug; 32(10):1059-64. PubMed ID: 3537355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Significance of anti-peptide monoclonal antibodies in the assessment of tumor markers].
    Bohuon C; Bellet D; Bidart JM; Motte P
    Bull Mem Acad R Med Belg; 1987; 142(4-5):268-75. PubMed ID: 2447985
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of calcitonin determinations by polyclonal and monoclonal IRMAs.
    Tommasi M; Raspanti S
    Clin Chem; 2007 Apr; 53(4):798-9. PubMed ID: 17405950
    [No Abstract]   [Full Text] [Related]  

  • 34. Some developments with tumour markers [proceedings].
    Bagshawe KD
    Arzneimittelforschung; 1979; 29(2):355-6. PubMed ID: 582150
    [No Abstract]   [Full Text] [Related]  

  • 35. [The development of immunoscintigraphy into a routine method].
    Pateisky N
    Wien Klin Wochenschr; 1990 Aug; 102(15):424-6. PubMed ID: 2205987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The effect of immunoscintigraphy using monoclonal antibodies on the analysis of hormones and tumor markers. This is not the end of it!].
    Verheijen RH; Schijf CP
    Ned Tijdschr Geneeskd; 1989 Sep; 133(35):1760. PubMed ID: 2797292
    [No Abstract]   [Full Text] [Related]  

  • 37. Tumor markers as targets for selective diagnostic and therapeutic procedures.
    Roselli M; Guadagni F; Buonomo O; Belardi A; Ferroni P; Diodati A; Anselmi D; Cipriani C; Casciani CU; Greiner J; Schlom J
    Anticancer Res; 1996; 16(4B):2187-92. PubMed ID: 8694541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antigenic markers in the cytological diagnosis of human malignant neoplasms].
    Frank GA; Pugachev KK; Shabalova IP; Shimbireva IB
    Arkh Patol; 1990; 52(8):70-4. PubMed ID: 2281989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Monoclonal antibodies in the diagnosis and therapy of malignant tumors: current status amd future perspectives].
    Obrist R
    Ther Umsch; 1988 Jun; 45(6):364-9. PubMed ID: 3413710
    [No Abstract]   [Full Text] [Related]  

  • 40. New approaches in gastric cancer research: I. Monoclonal antibodies in diagnosis and therapy.
    Juhl H
    Hepatogastroenterology; 1989 Feb; 36(1):27-32. PubMed ID: 2663689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.